4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-028150
Director acquired 57,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MALLIK AMEET Director | 2023-05-31 | Grant or award | +57,000 | 77,500 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MALLIK AMEET Director | 2023-05-31 | Grant or award · Non-Qualified Stock Option (Right to Buy) | +79,500 | 79,500 | D: show line 2 in the form |
Loading xslF345X04/form4.xml…